Profile | GDS4284 / 201924_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3378.51 | 90 |
GSM687648 | Patient 402 control | 5238.84 | 94 |
GSM687653 | Patient 403 control | 6342.4 | 95 |
GSM687658 | Patient 404 control | 5741.8 | 94 |
GSM687663 | Patient 411 control | 4439.52 | 92 |
GSM687668 | Patient 422 control | 3699.81 | 91 |
GSM687673 | Patient 424 control | 6914.24 | 95 |
GSM687678 | Patient 425 control | 5095.73 | 94 |
GSM687683 | Patient 427 control | 5889.85 | 95 |
GSM687688 | Patient 428 control | 670.91 | 68 |
GSM687695 | Patient 441 control | 9109.94 | 97 |
GSM687699 | Patient 443 control | 3201.34 | 90 |
GSM687704 | Patient 444 control | 5551.46 | 94 |
GSM687707 | Patient 448 control | 5249.09 | 94 |
GSM687712 | Patient 449 control | 7036.83 | 95 |
GSM687719 | Patient 450 control | 7912.48 | 96 |
GSM687724 | Patient 451 control | 4010.79 | 92 |
GSM687728 | Patient 452 control | 6439.39 | 95 |
GSM687646 | Patient 401 treated 24h | 3676.7 | 91 |
GSM687649 | Patient 402 treated 24h | 4855.37 | 93 |
GSM687665 | Patient 411 treated 24h | 4308.61 | 92 |
GSM687651 | Patient 402 treated 4 weeks | 5562.32 | 94 |
GSM687667 | Patient 411 treated 4 weeks | 3966.12 | 91 |
GSM687670 | Patient 422 treated 24h | 3795.55 | 91 |
GSM687671 | Patient 422 treated 4 weeks | 2988.05 | 89 |
GSM687654 | Patient 403 treated 24h | 7314.02 | 96 |
GSM687675 | Patient 424 treated 24h | 5914.7 | 95 |
GSM687685 | Patient 427 treated 24h | 5914.81 | 95 |
GSM687656 | Patient 403 treated 4 weeks | 5787.59 | 94 |
GSM687677 | Patient 424 treated 4 weeks | 5987.52 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 4757.59 | 93 |
GSM687692 | Patient 428 treated 4h | 1308.56 | 78 |
GSM687716 | Patient 449 treated 4h | 6860.09 | 95 |
GSM687722 | Patient 450 treated 4h | 7074.22 | 96 |
GSM687680 | Patient 425 treated 24h | 5251.51 | 94 |
GSM687690 | Patient 428 treated 24h | 1248.69 | 78 |
GSM687700 | Patient 443 treated 24h | 5071.29 | 94 |
GSM687705 | Patient 444 treated 24h | 6675.12 | 95 |
GSM687714 | Patient 449 treated 24h | 6611.43 | 95 |
GSM687721 | Patient 450 treated 24h | 6985.48 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 5027.7 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 964.929 | 73 |
GSM687702 | Patient 443 treated 4 weeks | 4868.86 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 6658.39 | 95 |
GSM687723 | Patient 450 treated 4 weeks | 6680.64 | 95 |
GSM687661 | Patient 404 treated 4h | 4688.7 | 93 |
GSM687710 | Patient 448 treated 4h | 5542.4 | 94 |
GSM687726 | Patient 451 treated 4h | 3564.49 | 91 |
GSM687730 | Patient 452 treated 4h | 3828.04 | 92 |
GSM687660 | Patient 404 treated 24h | 12718.1 | 97 |
GSM687697 | Patient 441 treated 24h | 10166.8 | 97 |
GSM687709 | Patient 448 treated 24h | 5903.51 | 94 |
GSM687725 | Patient 451 treated 24h | 3266.65 | 90 |
GSM687729 | Patient 452 treated 24h | 8028.58 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 4351.46 | 92 |
GSM687731 | Patient 452 treated 4 weeks | 7327.96 | 96 |